Associated Papers
Successful treatment of Afatinib plus Apatinib using for a lung adenocarcinoma patient with HER-2 V659D mutation: a rare case report.
Sun C et al.
Anti-cancer Drugs, 2021
Epidemiological study of HER-2 mutations among EGFR wild-type lung adenocarcinoma patients in China.
Li X et al.
Bmc Cancer, 2016
Select a paper to view details